Live feed
Filing
SC 13G/A
SC 13G/A0001622627-24-000027·Rosalind Advisors, Inc.
Schedule 13G ownership disclosure
Trevi Therapeutics Inc
Security class unavailable · CUSIP: 89532M101
Event date: 2024-03-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 926,016
- Percent of class
- 1.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001622627-24-000027
- Form type
- SC 13G/A
- Filer
- Rosalind Advisors, Inc.
- CIK
- CIK 1622627
- Filed
- Apr 25, 2024
- Reporting period
- Mar 31, 2024
- Description
- Schedule 13G beneficial ownership